ProMIS Neurosciences continues from CBCA into Ontario under OBCA

ProMIS Neurosciences Inc.

Continuance effective July 13, 2023; approved by shareholders on June 29, 2023.
Company now governed by Ontario Business Corporations Act; CBCA no longer applies.
No change in business, headquarters, management, assets, or Nasdaq/TSX listing.
OBCA has no director residency requirement; short selling by insiders not prohibited.
Shareholder rights generally comparable; some differences in dissent and oppression remedies.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ProMIS Neurosciences Inc.: Company continued from Canada Business Corporations Act to Business Corporations Act (Ontario), replacing its articles and bylaws with OBCA versions (effective 2023-07-13).

Change: charter amendment
Effective: 2023-07-13

Exact text from the filing

On July 13, 2023, ProMIS Neurosciences Inc. (the “Company”) continued its existence from a corporation incorporated under the Canada Business Corporations Act (“CBCA”) into the Province of Ontario under the Business Corporations Act (Ontario) (the “OBCA”) (the “Continuance”).

View on SEC.gov

59 governance changes filed in the last 30 days. Browse all governance changes →

ProMIS Neurosciences Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-011879

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.